Just - Evotec Biologics Enters Project Agreement with BARDA to Optimize Biomanufacturing of Antibodies Against Ebola and Related Viruses

Go back to Just - Evotec Biologics Enters Project Agreement with BARDA to Optimize Biomanufacturing of Antibodies Against Ebola and Related Viruses
EATON VANCE OHIO MUNI INCOME T (NASDAQ: EVO) Delayed: 2.62 --0 (-0%)
Previous Close $2.62    52 Week High $16.39 
Open $2.60    52 Week Low $13.22 
Day High $2.68    P/E N/A 
Day Low $2.60    EPS $-1.61 
Volume 20,109